708 filings
Page 6 of 36
DEFA14A
35y 2ygv7bxvbd
17 Mar 23
Additional proxy soliciting materials
7:02am
DEFA14A
8rn3dpnhpj9q3sjrf7k
16 Mar 23
Additional proxy soliciting materials
4:23pm
4
yjj5 y0h9gk
15 Mar 23
ZEVRA THERAPEUTICS / Joshua Schafer ownership change
8:14pm
PRRN14A
36np 8bhgy
15 Mar 23
Revised preliminary proxy statement filed by non-management
5:54pm
DEFA14A
rk8qey8orfu rta
15 Mar 23
Additional proxy soliciting materials
7:36am
DEFC14A
b1pg693xfbekutxceb1
15 Mar 23
Proxy in contested solicitation
7:03am
4
sgz4aci9 wtkx
13 Mar 23
ZEVRA THERAPEUTICS / Matthew R Plooster ownership change
7:59am
4
jd1596vi8 t91go
13 Mar 23
ZEVRA THERAPEUTICS / Timothy J. Sangiovanni ownership change
7:57am
4
j32p109s hici
13 Mar 23
ZEVRA THERAPEUTICS / R. LaDuane Clifton ownership change
7:56am
4
8x71r
13 Mar 23
ZEVRA THERAPEUTICS / David S Tierney ownership change
7:54am
4
crx35sj1iq6 ze
13 Mar 23
ZEVRA THERAPEUTICS / Richard W Pascoe ownership change
7:53am
8-K
eha1l
13 Mar 23
Regulation FD Disclosure
6:25am
UPLOAD
ib27y7r297x knm
10 Mar 23
Letter from SEC
12:00am
S-8
jolr 6o9ggm5a3n
7 Mar 23
Registration of securities for employees
5:29pm
S-8
1u33k0 8d1fljfwd78
7 Mar 23
Registration of securities for employees
5:28pm
DEFA14A
pkw8k1
7 Mar 23
Additional proxy soliciting materials
4:42pm
8-K
sfg8k
7 Mar 23
Zevra Therapeutics Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Corporate Updates
8:20am
PRER14A
pvpscph5
6 Mar 23
Preliminary revised proxy
4:39pm